This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

LACOSAMIDE

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20231003

Version

2

Spl Product Data Elements

LACOSAMIDE Lacosamide LACOSAMIDE LACOSAMIDE HYDROCHLORIC ACID SODIUM CHLORIDE WATER

Application Number

ANDA209465

Brand Name

LACOSAMIDE

Generic Name

Lacosamide

Product Ndc

70771-1682

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAVENOUS

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1682-1 Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL); CV For Intravenous Use Only 20 mL single-dose vial Rx only NDC 70771-1682-6 Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL); CV For Intravenous Use Only 10 X 20 mL Single-dose vials Rx only vial label carton label

Spl Medguide

SPL MEDGUIDE

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.